Editorial comment on "Maintenance bacillus Calmette-Guerin therapy for nonmuscle-invasive bladder cancer: A need for more randomized trials"

被引：0
|
作者：
Huang, Shu-Pin [1 ,2 ]
机构：
[1] Kaohsiung Med Univ Hosp, Dept Urol, 100 Tz You 1st Rd, Kaohsiung 807, Taiwan
[2] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Urol, Kaohsiung, Taiwan
来源：
UROLOGICAL SCIENCE | 2015年 / 26卷 / 02期
关键词：
D O I：
10.1016/j.urols.2015.04.005
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：101 / +
页数：2
相关论文
共 50 条
  • [21] Single course of intravesical Bacillus Calmette-Guerin versus single course with maintenance therapy in the management of nonmuscle invasive bladder cancer: A prospective randomized study
    Mohamed, Mohamed Bakr
    Ali, Mohamed Hassan
    Shamaa, Mostafa A.
    Shaaban, Sami M.
    UROLOGY ANNALS, 2020, 12 (04) : 360 - 365
  • [22] Discontinuance of Bacille Calmette-Guerin Instillation Therapy for Nonmuscle-invasive Bladder Cancer Has Negative Effect on Tumor Recurrence
    Takeda, Toshikazu
    Kikuchi, Eiji
    Yuge, Kazuyuki
    Matsumoto, Kazuhiro
    Miyajima, Akira
    Nakagawa, Ken
    Oya, Mototsugu
    UROLOGY, 2009, 73 (06) : 1318 - 1322
  • [23] Contemporary Outcomes of Patients with Nonmuscle-Invasive Bladder Cancer Treated with bacillus Calmette-Guerin: Implications for Clinical Trial Design REPLY
    不详
    JOURNAL OF UROLOGY, 2021, 205 (06): : 1620 - 1621
  • [24] Diminished Efficacy of Bacille Calmette-Guerin Among Elderly Patients with Nonmuscle Invasive Bladder Cancer EDITORIAL COMMENT
    Lamm, Donald L.
    UROLOGY, 2011, 78 (04) : 854 - 855
  • [25] Dose, duration and strain of bacillus Calmette-Guerin in the treatment of nonmuscle invasive bladder cancer: Meta-analysis of randomized clinical trials
    Quan, Yongjun
    Jeong, Chang Wook
    Kwak, Cheol
    Kim, Hyeon Hoe
    Kim, Hyung Suk
    Ku, Ja Hyeon
    MEDICINE, 2017, 96 (42)
  • [26] Effectiveness of the Moreau strain of Bacillus Calmette-Guerin (BCG) for nonmuscle invasive bladder cancer.
    Chade, Daher Cezar
    Machado, Andre
    Waksman, Ricardo
    Garcia, Guilherme
    Esteves, Paulo
    Adonias, Sanarelly
    Botelho, Luis
    Cordeiro, Mauricio
    Murta, Claudio
    Ribeiro-Filho, Leopoldo
    Sarkis, Alvaro
    Bastos, Diogo Assed
    Dzik, Carlos
    Srougi, Miguel
    Nahas, William Carlos
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [27] The prognostic value of cytology and fluorescence in situ hybridization in the follow-up of nonmuscle-invasive bladder cancer after intravesical Bacillus Calmette-Guerin therapy
    Savic, Spasenija
    Zlobec, Inti
    Thalmann, George N.
    Engeler, Daniel
    Schmauss, Martina
    Lehmann, Kurt
    Mattarelli, Gianfranco
    Eichenberger, Tobias
    Dalquen, Peter
    Spieler, Peter
    Schoenegg, Rene
    Gasser, Thomas C.
    Sulser, Tullio
    Forster, Thomas
    Zellweger, Tobias
    Casella, Roberto
    Bubendorf, Lukas
    INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (12) : 2899 - 2904
  • [28] Adding mitomycin to Bacillus Calmette-Guerin as adjuvant intravesical therapy for high-risk, nonmuscle-invasive urothelial bladder cancer (BCGMM; ANZUP 1301)
    Liow, Elizabeth Chien Hern
    Hayne, Dickon
    Stockler, Martin R.
    Martin, Andrew James
    Sengupta, Shomik
    Anderson, Paul
    Ford, Kate
    Frydenberg, Mark
    Gorzeman, Margot
    Green, Will
    Grummet, Jeremy
    Hawks, Cynthia
    Krieger, Laurence Eliot Miles
    Ischia, Joseph
    McCombie, Steve
    Patel, Manish
    Davis, Ian D.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [29] Re: Diminished Efficacy of Bacille Calmette-Guerin Among Elderly Patients With Nonmuscle Invasive Bladder Cancer Editorial Comment
    Griebling, Tomas L.
    JOURNAL OF UROLOGY, 2012, 187 (03): : 879 - 880
  • [30] A Prospective Comparative Study of Intravesical Bacillus Calmette-Guerin Therapy with the Tokyo or Connaught Strain for Nonmuscle Invasive Bladder Cancer
    Sengiku, Atsushi
    Ito, Masaaki
    Miyazaki, Yu
    Sawazaki, Harutake
    Takahashi, Takeshi
    Ogura, Keiji
    JOURNAL OF UROLOGY, 2013, 190 (01): : 50 - 54
12345